Latest Ratios: P/E Ratio N/A · EV/EBITDA N/A · ROE N/A. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | — | $33.1B | $41.4B | $41.2B | — | — | — |
| Enterprise Value | — | $40.5B | $49.1B | $48.3B | — | — | — |
| P/E Ratio → | — | 22.62 | 39.87 | 24.75 | — | — | — |
| P/S Ratio | — | 2.19 | 2.68 | 2.67 | — | — | — |
| P/B Ratio | — | 3.07 | 4.28 | 3.68 | — | — | — |
| P/FCF | — | 19.21 | 31.01 | 15.28 | — | — | — |
| P/OCF | — | 15.05 | 23.40 | 13.01 | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.68 | 3.17 | 3.13 | — | — | — |
| EV / EBITDA | — | 12.43 | 19.92 | 15.38 | — | — | — |
| EV / EBIT | — | 17.05 | 26.57 | 18.95 | — | — | — |
| EV / FCF | — | 23.54 | 36.74 | 17.89 | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | — | 58.1% | 58.0% | 56.0% | 55.4% | 55.9% | 54.2% |
| Operating Margin | — | 17.9% | 11.9% | 16.3% | 17.9% | 19.4% | -6.8% |
| Net Profit Margin | — | 9.7% | 6.7% | 10.8% | 13.8% | 13.8% | -6.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | — | 14.4% | 9.9% | 10.7% | 10.2% | 10.7% | -4.8% |
| ROA | — | 5.6% | 3.9% | 6.0% | 7.5% | 7.3% | -3.0% |
| ROIC | — | 11.4% | 7.8% | 8.2% | 8.4% | 11.7% | -4.1% |
| ROCE | — | 13.2% | 8.7% | 11.0% | 11.3% | 12.8% | -4.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | — | 0.79 | 0.90 | 0.75 | 0.45 | 0.01 | — |
| Debt / EBITDA | — | 2.61 | 3.54 | 2.68 | 2.73 | 0.04 | — |
| Net Debt / Equity | — | 0.69 | 0.79 | 0.63 | 0.39 | -0.03 | -0.03 |
| Net Debt / EBITDA | — | 2.29 | 3.11 | 2.24 | 2.35 | -0.17 | — |
| Debt / FCF | — | 4.33 | 5.73 | 2.61 | 3.63 | -15.67 | -0.20 |
| Interest Coverage | — | 6.27 | 4.28 | 7.12 | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | — | 0.96 | 0.96 | 1.12 | 1.50 | 1.22 | 0.61 |
| Quick Ratio | — | 0.68 | 0.69 | 0.78 | 0.93 | 0.80 | 0.39 |
| Cash Ratio | — | 0.18 | 0.19 | 0.25 | 0.31 | 0.18 | 0.08 |
| Asset Turnover | — | 0.56 | 0.60 | 0.55 | 0.55 | 0.54 | 0.50 |
| Inventory Turnover | — | 3.80 | 4.08 | 3.67 | 2.99 | 3.90 | 3.93 |
| Days Sales Outstanding | — | 67.91 | 62.80 | 62.39 | 56.08 | 56.52 | 53.74 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | 4.8% | 3.7% | 35.3% | — | — | — |
| Payout Ratio | — | 107.6% | 150.7% | 874.6% | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | 4.4% | 2.5% | 4.0% | — | — | — |
| FCF Yield | — | 5.2% | 3.2% | 6.5% | — | — | — |
| Buyback Yield | — | 0.6% | 0.6% | 0.0% | — | — | — |
| Total Shareholder Yield | — | 5.4% | 4.3% | 35.3% | — | — | — |
| Shares Outstanding | — | $1.9B | $1.9B | $1.9B | $1.9B | $1.9B | $1.9B |
Includes 30+ ratios · 6 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying KVUE stock.
Based on historical data, Kenvue Inc. is trading at valuation metrics that vary. Compare with industry peers and growth rates for a complete picture.
Key Metrics
Top Statement Risk
Unresolved Kimberly-Clark deal overhang
Metrics are mathematically derived from official filings.
Premium Multiples Imply Recovery Priced In
Based on Kenvue's reported figures, the trailing P/E of 25.41 compresses to 16.43 on forward earnings, implying the market expects meaningful earnings recovery that trailing twelve-month results have not yet demonstrated.
The gap between trailing and forward P/E suggests investors are capitalizing an earnings trajectory rather than current results. Against a 13.66 EV/EBITDA multiple, the valuation appears to embed continued margin improvement, which warrants monitoring given the still-negative trailing revenue growth. Relative to Procter & Gamble at a 25.24 trailing P/E, Kenvue screens roughly in line on trailing earnings but without P&G's returns profile, so the pricing appears to rest on execution rather than demonstrated compounding.
Margin Recovery Outpaces Return Generation
As reported in the quarterly statements, operating margin rose from 3.9% in Q2 2024 to 18.2% in Q3 2026, yet ROIC of 3.0% remains far below the 18.9% achieved by Procter & Gamble, indicating margin gains have not yet translated into capital efficiency.
Gross margin has held in a 56.5% to 59.5% band, which may reflect durable brand pricing power across the Self Care and Skin Health portfolio. The sharp operating margin swing, however, includes a peak of 21.9% in Q1 2026 that did not hold, suggesting part of the improvement may be transitional rather than structural. The low ROIC relative to peers implies that the large goodwill-laden asset base is diluting returns on the capital employed.
Goodwill-Heavy Base Caps Returns
Based on Kenvue's reported quarterly figures, ROE improved from 0.6% in Q2 2024 to 4.2% in Q3 2026 while ROA reached 1.6%, a trajectory that appears driven more by earnings recovery than by any gain in asset efficiency.
With goodwill of $9.3B representing roughly 35% of total assets, the return denominator is dominated by acquired brand value, which mechanically depresses ROIC and ROA. The improvement in ROE may partly reflect a recovering numerator rather than improved capital deployment. Investors should monitor whether returns can sustain above the sub-5% range given the asset base composition.
Debt Service Comfort Improving Gradually
According to recent SEC filings, Kenvue's interest coverage improved from 1.61x in Q2 2024 to 6.86x in Q3 2026, while debt-to-EBITDA stands at 9.82x, suggesting debt service has become more comfortable even as absolute leverage remains elevated.
The rise in interest coverage appears to reflect operating income recovery rather than debt reduction, since total debt declined only modestly. A debt-to-EBITDA ratio near 10x may indicate limited headroom should earnings soften again. Refinancing risk and covenant flexibility warrant further investigation given reported cash of $1.0B covers only about 12% of total debt.
Thin Liquidity Buffer Under Stress
Based on Kenvue's reported figures, the current ratio of 0.96 and quick ratio of 0.66 indicate current liabilities modestly exceed current assets, leaving limited liquid reserves relative to operating obligations.
A quick ratio below 0.7 means the company depends on inventory conversion and ongoing receivable collection to meet near-term obligations. Under a severe demand shock, reliance on working capital inflows could tighten quickly. The balance sheet appears adequate in normal conditions but offers limited cushion if cash generation weakens while dividend commitments remain fixed.
Margin Gains May Not Be Durable
As reported in the quarterly statements, the operating margin peaked at 21.9% in Q1 2026 before settling near 18%, and the bear case rests on whether this recovery reflects transitional cost benefits rather than structural improvement.
Short-side arguments would point to the volatility in operating margin and the still-negative trailing revenue growth as evidence that the recent earnings lift may be cyclical or tied to temporary separation-related cost timing. If that proves correct, the current forward P/E of 16.43 could look less conservative than it appears. Monitoring whether ROIC can move meaningfully above 3% would help distinguish durable improvement from a temporary rebound.